Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88182290 |
LAW OFFICE ASSIGNED |
LAW OFFICE 108 |
MARK SECTION |
MARK |
RIABNI (see, http://uspto.report/TM/88182290/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
RIABNI |
OWNER SECTION (current) |
NAME |
Amgen Inc. |
MAILING ADDRESS |
One Amgen Center Drive |
CITY |
Thousand Oaks |
STATE |
California |
ZIP/POSTAL CODE |
91320-1799 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
OWNER SECTION (proposed) |
NAME |
Amgen Inc. |
INTERNAL ADDRESS |
Trademark Operations - MS-28-5A |
MAILING ADDRESS |
One Amgen Center Drive |
CITY |
Thousand Oaks |
STATE |
California |
ZIP/POSTAL CODE |
91320-1799 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
805-447-3278 |
EMAIL |
XXXX |
ATTORNEY INFORMATION (current) |
NAME |
Timothy J. Gaul |
ATTORNEY BAR MEMBERSHIP NUMBER |
NOT SPECIFIED |
YEAR OF ADMISSION |
NOT SPECIFIED |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
NOT SPECIFIED |
FIRM NAME |
Amgen Inc. |
INTERNAL ADDRESS |
Trademark Operations |
STREET |
One Amgen Center Drive |
CITY |
Thousand Oaks |
STATE |
California |
POSTAL CODE |
91320-1799 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
805-447-2688 |
EMAIL |
tmops@amgen.com |
ATTORNEY INFORMATION (proposed) |
NAME |
Timothy J. Gaul |
ATTORNEY BAR MEMBERSHIP NUMBER |
XXX |
YEAR OF ADMISSION |
XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
XX |
FIRM NAME |
Amgen Inc. |
INTERNAL ADDRESS |
Trademark Operations-MS-28-5A |
STREET |
One Amgen Center Drive |
CITY |
Thousand Oaks |
STATE |
California |
POSTAL CODE |
91320-1799 |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
PHONE |
805-447-3278 |
EMAIL |
tmops@amgen.com |
DOCKET/REFERENCE NUMBER |
TM-1826-US-1 |
OTHER APPOINTED ATTORNEY |
Elsa D. Lemoine, Timothy J. Gaul, Richard V. Person, Stuart L. Watt |
CORRESPONDENCE INFORMATION (current) |
NAME |
Timothy J. Gaul |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
tmops@amgen.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Timothy J. Gaul |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
tmops@amgen.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
elemoine@amgen.com |
DOCKET/REFERENCE NUMBER |
TM-1826-US-1 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceutical preparations for treatment of oncologic, inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for
treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the blood, skin, bone marrow, nervous system, immune system and joints; pharmaceutical preparations for
treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), pemphigus vulgaris
(PV), multiple sclerosis (MS), and stem cell transplantation |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
1 |
ALLOWANCE MAIL DATE |
11/05/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
125 |
TOTAL AMOUNT |
125 |
SIGNATURE SECTION |
SIGNATURE |
/Elsa D. Lemoine/ |
SIGNATORY'S NAME |
Lemoine, Elsa D. |
SIGNATORY'S POSITION |
Attorney of Record, California Bar member |
DATE SIGNED |
04/28/2020 |
SIGNATORY'S PHONE NUMBER |
805-447-3278 |
FILING INFORMATION |
SUBMIT DATE |
Tue Apr 28 15:27:40 ET 2020 |
TEAS STAMP |
USPTO/ESU-XXX.XXX.XXX.XXX
-20200428152740844970-881
82290-7101e9578cbbc978ddf
f2c69c41a4f379e06134dbd65
cacfbd907412d98ef784-DA-2
7406837-20200428130640685
460 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: RIABNI (see, http://uspto.report/TM/88182290/mark.png)
SERIAL NUMBER: 88182290
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Amgen Inc., having an address of
One Amgen Center Drive
Thousand Oaks, California 91320-1799
United States
Proposed: Amgen Inc., having an address of
Trademark Operations - MS-28-5A
One Amgen Center Drive
Thousand Oaks, California 91320-1799
United States
Phone: 805-447-3278
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 11/05/2019.
For International Class 005:
Current identification: Pharmaceutical preparations for treatment of oncologic, inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis;
pharmaceutical preparations for treatment of diseases and disorders of the blood, skin, bone marrow, nervous system, immune system and joints; pharmaceutical preparations for treatment of
non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), pemphigus vulgaris (PV), multiple
sclerosis (MS), and stem cell transplantation
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the first extension request.
The applicant's current Attorney Information:
Timothy J. Gaul Amgen Inc.
Trademark Operations
One Amgen Center Drive
Thousand Oaks, California 91320-1799
United States
Phone: 805-447-2688
Email: tmops@amgen.com
The applicant's proposed Attorney Information:
Timothy J. Gaul Amgen Inc.
Trademark Operations-MS-28-5A
One Amgen Center Drive
Thousand Oaks, California 91320-1799
United States
Phone: 805-447-3278
The docket/reference number is TM-1826-US-1
Email: tmops@amgen.com
Correspondence Information (current):
Timothy J. Gaul
PRIMARY EMAIL FOR CORRESPONDENCE: tmops@amgen.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Correspondence Information (proposed):
Timothy J. Gaul
PRIMARY EMAIL FOR CORRESPONDENCE: tmops@amgen.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): elemoine@amgen.com
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /Elsa D. Lemoine/ Date Signed: 04/28/2020
Signatory's Name: Lemoine, Elsa D.
Signatory's Position: Attorney of Record, California Bar member
Signatory's Phone: 805-447-3278
Mailing Address:
Amgen Inc.
Trademark Operations-MS-28-5A
One Amgen Center Drive
Thousand Oaks, California 91320-1799
RAM Sale Number: 88182290
RAM Accounting Date: 04/28/2020
Serial Number: 88182290
Internet Transmission Date: Tue Apr 28 15:27:40 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XXX.XXX.XXX-20200428152740
844970-88182290-7101e9578cbbc978ddff2c69
c41a4f379e06134dbd65cacfbd907412d98ef784
-DA-27406837-20200428130640685460